Heron Therapeutics (HRTX) Q3 2023 Earnings

Nov 14Confirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-0.35
-0.29
-0.23
-0.17

Details

Expected EPS
-0.29
Actual EPS
-0.17
Surprise EPS
0.12
Surprise Percent
+41.38%

Description

⁨Heron Therapeutics⁩ (⁦HRTX⁩) has reported earnings of ⁦-0.17⁩ per share for ⁦Q3 2023⁩.

0 Comments

Share your thoughts